Bayesian Inference for the Lead Time in Periodic Cancer Screening

DOI10.1111/J.1541-0420.2006.00732.XMaRDI QIDQ5434920zbMATH OpenOpenAlexWikidataFDO

Authors Dongfeng Wu, Gary L. Rosner, Lyle D. Broemeling

Publication date 14 January 2008

Published in Biometrics (Search for Journal in Brave)

Full work available at URL http://europepmc.org/articles/pmc2020448

zbMATH Keywords

breast cancerearly detectionperiodic screening examssensitivitysojourn timetransition probability

Mathematics Subject Classification ID

Bayesian inference (62F15) Estimation in survival analysis and censored data (62N02) Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• Estimating Lead Time and Sensitivity in a Screening Program without Estimating the Incidence in the Screened Group
• Simplified Models of Screening for Chronic Disease: Estimation Procedures from Mass Screening Programmes
• MLE and Bayesian Inference of Age-Dependent Sensitivity and Transition Probability in Periodic Screening
• Probability modeling and statistical inference in periodic cancer screening
• A review of estimation of key parameters and lead time in cancer screening

Cites work

• An Estimate of the Variance of Estimators for Lead Time and Screening Benefit Time in Randomized Cancer Screening Trials
• Bounded Recurrence times and lead time in the design of a repetitive screening program
• Computer simulation of randomized cancer screening trials to compare methods of estimating lead time and benefit time
• Estimating Lead Time and Sensitivity in a Screening Program without Estimating the Incidence in the Screened Group
• scientific article; zbMATH DE number 1739743 (Why is no real title available?)
• MLE and Bayesian Inference of Age-Dependent Sensitivity and Transition Probability in Periodic Screening
• On the theory of screening for chronic diseases
• Optimal scheduling of examinations for the early detection of disease

Cited in

(13)

• Approximate models and robust decisions
• Screening for chronic diseases: optimizing lead time through balancing prescribed frequency and individual adherence
• Bayesian assessment of times to diagnosis in breast cancer screening
• MLE and Bayesian Inference of Age-Dependent Sensitivity and Transition Probability in Periodic Screening
• An Estimate of the Variance of Estimators for Lead Time and Screening Benefit Time in Randomized Cancer Screening Trials
• Estimating Lead Time and Sensitivity in a Screening Program without Estimating the Incidence in the Screened Group
• Evaluating the Age to Begin Periodic Breast Cancer Screening Using Data from a Few Regularly Scheduled Screenings
• A review of estimation of key parameters and lead time in cancer screening
• Probability modeling and statistical inference in periodic cancer screening
• Inference of long term effects and overdiagnosis in periodic cancer screening
• Estimating Lead Time and Overdiagnosis Associated with PSA Screening from Prostate Cancer Incidence Trends
• Evaluating cancer screening programs using survival analysis
• Computer simulation of randomized cancer screening trials to compare methods of estimating lead time and benefit time

This page was built for publication: Bayesian Inference for the Lead Time in Periodic Cancer Screening

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5434920)